Media formats available:
Recommended
- CME/CE
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
0.50 creditsJavier Cortes, MD, PhD
Komal Jhaveri, MD, FACP
- Oncology and Hematology
SunRISe-1: TAR-200 in BCG-Unresponsive High-Risk Bladder Cancer
- Oncology and Hematology
Evolving Trends in Germline Genetic Testing for Prostate Cancer
- Oncology and Hematology
Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer